Ratnakar Securities Pvt. Ltd.

OXYGENTA PHARMACEUTICAL LTD.

NSE : NABSE : 524636ISIN CODE : INE102E01018Industry : Pharmaceuticals & DrugsHouse : Private

BSE124.400.65 (+0.53 %)

PREV CLOSE ( ) 123.75

OPEN PRICE ( ) 129.00

BID PRICE (QTY) 121.20 (663)

OFFER PRICE (QTY) 124.30 (83)

VOLUME 3319

TODAY'S LOW / HIGH ( )121.00 129.00

52 WK LOW / HIGH ( ) 30133.5

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 27-11 1990

Management Info

- Chairman Sai Sudhakar Vankineni - Managing Director

Registered Office

Address Survey No. 252/1,Aroor Village,Sadasivapet Mandal,
Sangareddy,
Telangana-502291

Phone 08455-250080 / 25080

Email info@oxygentapharma.com / cs@oxygentapharma.com

Website www.oxygentapharma.com

Registrars Details

Venture Capital & Corporate Investments Ltd

Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57,4th & 5th Floors,Jayabheri Enclave Phase - II, Gachibowli,Hyderabad

Listing : BSE

NEWS

06Jun Oxygenta Pharmaceutical informs about
Oxygenta Pharmaceutical has informed that the exchange has received the..

02Jun Oxygenta Pharmaceutical informs about
Oxygenta Pharmaceutical has informed that the exchange has received the..

28Apr Oxygenta Pharmaceutical informs about
Oxygenta Pharmaceutical has informed that the exchange has received the..

31Mar Oxygenta Pharmaceutical informs about
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regu..

18Oct Oxygenta Pharmaceutical informs about
Oxygenta Pharmaceutical has informed about the certificate dated October..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	-21.52	-102.97
Gross Profit	-37.98	-143.5
Operating Profit	-16.34	-86.8399999999999
Net Sales	494.67	1092.99

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 32879.95 (3.75%)	M.Cap ( in Cr)67668.40
Sanofi India (BSE) 6170.45 (1.66%)	M.Cap ( in Cr)13984.77
Pfizer (BSE) 5668.85 (1.64%)	M.Cap ( in Cr)25818.19
Procter&Gamble Healt (BSE) 5950.00 (0.70%)	M.Cap ( in Cr)9820.28
Glaxosmithkline Phar (BSE) 3295.55 (1.00%)	M.Cap ( in Cr)55475.39

Shareholding Pattern

	PROMOTERS	51.12%
	NON-INSTITUTION	48.85%
	MUTUAL FUNDS/UTI	0.03%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

OXYGENTA PHARMACEUTICAL LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES